⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22851591 | 0.81 | — | — | |
| SCHEMBL7614770 | 0.81 | — | — | |
| SCHEMBL16532931 | 0.79 | — | — | |
| SCHEMBL22790562 | 0.79 | MAOA (0.34) | — | |
| SCHEMBL19204201 | 0.79 | MAOA (0.34) | — | |
| SCHEMBL1717828 | 0.77 | HMGCR (0.41) | — | |
| SCHEMBL41886 | 0.77 | — | — | |
| SCHEMBL22805178 | 0.75 | TDP1 (0.36) | — | |
| SCHEMBL18743815 | 0.75 | KDM4E (0.38) | — | |
| SCHEMBL19944905 | 0.75 | PIK3CD (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2950793-B1 | COMPOSITION FOR TREATMENT OF PATHOGENS THAT ARE RESISTANT TO TETRACYCLINES | BioVersys AG (CH) | 2020-04-01 | — | — | EP | claimed |
| US-9682079-B2 | Composition for treatment of pathogens that are resistant to tetracyclines | BioVersys AG (CH) | 2017-06-20 | — | — | US | claimed |
| US-20150359791-A1 | COMPOSITION FOR TREATMENT OF PATHOGENS THAT ARE RESISTANT TO TETRACYCLINES | BioVersys AG (CH) | 2015-12-17 | — | — | US | claimed |
| EP-2950793-A1 | COMPOSITION FOR TREATMENT OF PATHOGENS THAT ARE RESISTANT TO TETRACYCLINES | Bioversys AG (CH) | 2015-12-09 | — | — | EP | claimed |
| WO-2014118361-A1 | COMPOSITION FOR TREATMENT OF PATHOGENS THAT ARE RESISTANT TO TETRACYCLINES | BioVersys AG (CH) | 2014-08-07 | — | — | WO | claimed |
| EP-2762134-A1 | Composition for treatment of pathogens that are resistant to tetracyclines | Bioversys AG (CH) | 2014-08-06 | — | — | EP | claimed |
| WO-2008097851-A1 | TETRACYCLINE COMPOSITIONS FOR TOPICAL ADMINISTRATION | WARNER CHILCOTT COMPANY, INC. (US) | 2008-08-14 | — | — | WO | claimed |
| WO-2008097850-A1 | TRETRACYCLINE COMPOSITIONS FOR TOPICAL ADMINISTRATION | WARNER CHILCOTT COMPANY, INC. (US) | 2008-08-14 | — | — | WO | claimed |
| US-20080188445-A1 | TETRACYCLINE COMPOSITIONS FOR TOPICAL ADMINISTRATION | WARNER CHILCOTT COMPANY INC. (US) | 2008-08-07 | — | — | US | claimed |
| US-20080188446-A1 | TETRACYCLINE COMPOSITIONS FOR TOPICAL ADMINISTRATION | WARNER CHILCOTT COMPANY INC. (US) | 2008-08-07 | — | — | US | claimed |
| EP-1575947-A1 | 2-OXOPYRIDIN-3-YL THIA(DI)AZOLE DERIVATIVES FOR USE IN THE TREATMENT OF CELL PROLIFERATION AND APOPTOSIS RELATED DISEASES | Amgen Inc. (US) | 2005-09-21 | — | — | EP | claimed |
| US-20040147561-A1 | Pyrid-2-one derivatives and methods of use | SYNGENTA CROP PROTECTION AG (CH) | 2004-07-29 | — | — | US | claimed |
| WO-2004060890-A1 | 2-OXOPYRIDIN-3-YL THIA (DI) AZOLE DERIVATES FOR USE IN THE TREATMENT OF CELL PROLIFERATION AND APOPTOSIS RELATED DISEASES | AMGEN INC. (US) | 2004-07-22 | — | — | WO | claimed |
| EP-0796646-B1 | Method for the removal of carbon dioxide present in gases and absorbent | KANSAI ELECTRIC POWER CO (JP) | 2003-11-12 | — | — | EP | claimed |
| US-5904908-A | USING AN AQUEOUS SOLUTION CONTAINING AN ALKYLAMINOAMIDE COMPOUND | MITSUBISHI HEAVY INDUSTRIES, LTD. (JP) | 1999-05-18 | — | — | US | claimed |
| EP-0796646-A1 | Method for the removal of carbon dioxide present in gases and absorbent | THE KANSAI ELECTRIC POWER CO., INC. (JP) | 1997-09-24 | — | — | EP | claimed |
| US-20230348493-A1 | COMPOUND FOR ADJUSTING ACTIVITY OF NMDA RECEPTOR, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF | BEIJING GREATWAY PHARMACEUTICAL TECHNOLOGY CO. LTD. (CN) | 2023-11-02 | — | — | US | disclosed |
| CN-116942683-A | Antimicrobial composition and application thereof | 江苏奥赛康药业有限公司 | 2023-10-27 | — | — | CN | disclosed |
| US-5672615-A | MATRIX-DEGRADING METALLOPROTEINASE INHIBITORS | NOVARTIS CORPORATION (US) | 1997-09-30 | — | — | US | disclosed |
| EP-0796646-A1 | Method for the removal of carbon dioxide present in gases and absorbent | THE KANSAI ELECTRIC POWER CO., INC. (JP) | 1997-09-24 | — | — | EP | disclosed |